These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 33388022)
61. THE MAIN CAUSES OF THE COMPLICATED COURSE OF COVID-19 IN PATIENTS WITH DIABETES MELLITUS AND TREATMENT (REVIEW). Halushko O; Loskutov O; Kuchynska I; Synytsyn M; Boliuk M Georgian Med News; 2020 Oct; (307):114-120. PubMed ID: 33270588 [TBL] [Abstract][Full Text] [Related]
62. The Potential Impact of Statins in the Treatment of Patients with COVID-19 Infection. Esfehani RJ; Vojdanparast M; Soleimanpour S; Ferns GA; Avan A Adv Exp Med Biol; 2021; 1352():149-158. PubMed ID: 35132599 [TBL] [Abstract][Full Text] [Related]
63. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220 [TBL] [Abstract][Full Text] [Related]
64. Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management. Karavanaki K; Rodolaki K; Soldatou A; Karanasios S; Kakleas K Endocrine; 2023 May; 80(2):237-252. PubMed ID: 36462147 [TBL] [Abstract][Full Text] [Related]
65. Association of Diabetes Mellitus with Coronavirus Disease 2019 Severity: A Retrospective Study from a Center in South Western Nigeria. Esan A; Azeez TA; Adekanmbi O; Raji YR; Idowu O; Fowotade A West Afr J Med; 2022 Oct; 39(10):1007-1012. PubMed ID: 36260053 [TBL] [Abstract][Full Text] [Related]
66. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection. Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656 [TBL] [Abstract][Full Text] [Related]
67. New-onset diabetes in COVID-19: The molecular pathogenesis. Wihandani DM; Purwanta MLA; Mulyani WRW; Putra IWAS; Supadmanaba IGP Biomedicine (Taipei); 2023; 13(1):3-12. PubMed ID: 37168726 [TBL] [Abstract][Full Text] [Related]
68. The Impact of Obesity on SARS-CoV-2 Pandemic Mortality Risk. Li Z; Surampudi V; Heber D Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684447 [TBL] [Abstract][Full Text] [Related]
69. COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes. Mason K; Hasan S; Darukhanavala A; Kutney K J Clin Transl Endocrinol; 2021 Dec; 26():100268. PubMed ID: 34722160 [TBL] [Abstract][Full Text] [Related]
70. A Case of New-onset Autoimmune Type-1 Diabetes Mellitus Following COVID-19 Infection. Taşkaldıran I; Nar A Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1455-1457. PubMed ID: 37076470 [TBL] [Abstract][Full Text] [Related]
71. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients. Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321 [TBL] [Abstract][Full Text] [Related]
72. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes. Tong ZWM; Grant E; Gras S; Wu M; Smith C; Barrett HL; Gallo LA; Short KR FEBS J; 2021 Sep; 288(17):5042-5054. PubMed ID: 34216102 [TBL] [Abstract][Full Text] [Related]
73. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review. Yin Y; Rohli KE; Shen P; Lu H; Liu Y; Dou Q; Zhang L; Kong X; Yang S; Jia P Prim Care Diabetes; 2021 Dec; 15(6):899-909. PubMed ID: 34600859 [TBL] [Abstract][Full Text] [Related]
74. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Corrao S; Pinelli K; Vacca M; Raspanti M; Argano C Front Endocrinol (Lausanne); 2021; 12():609470. PubMed ID: 33868163 [TBL] [Abstract][Full Text] [Related]
75. Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus. Roham PH; Kamath JJ; Sharma S Adv Biol (Weinh); 2023 Aug; 7(8):e2300107. PubMed ID: 37246237 [TBL] [Abstract][Full Text] [Related]
76. Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Tallon EM; Gallagher MP; Staggs VS; Ferro D; Murthy DB; Ebekozien O; Kosiborod MN; Lind M; Manrique-Acevedo C; Shyu CR; Clements MA BMJ Open; 2023 Jul; 13(7):e071475. PubMed ID: 37423628 [TBL] [Abstract][Full Text] [Related]
77. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Norouzi M; Norouzi S; Ruggiero A; Khan MS; Myers S; Kavanagh K; Vemuri R Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34205044 [TBL] [Abstract][Full Text] [Related]
78. Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection. Nouri-Keshtkar M; Taghizadeh S; Farhadi A; Ezaddoustdar A; Vesali S; Hosseini R; Totonchi M; Kouhkan A; Chen C; Zhang JS; Bellusci S; Tahamtani Y Front Cell Dev Biol; 2021; 9():676150. PubMed ID: 34307358 [TBL] [Abstract][Full Text] [Related]
79. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic. Kow CS; Hasan SS Obes Surg; 2021 Jan; 31(1):413-414. PubMed ID: 32583299 [No Abstract] [Full Text] [Related]
80. Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus. Martorina WJ; Tavares A Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):18-21. PubMed ID: 34259775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]